The chemiluminescence immunoassay (CLIA) market is expected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by ...

COVID-19 is fast. To beat it, we must be faster. That’s why UC Santa Barbara has established its own CLIA-certified laboratory, enabling the speedy clinical-level testing and medical diagnosis needed ...

Sensitivity Diagnostic Testing and Automated Laboratory Systems Continues to Drive Global CLIA Market GrowthDelray Beach, FL, ...

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that ...

HealthLabs.com, operated by FPK Services, is expanding access to private direct-to-consumer lab testing through its nati ...

In 2019, the first cases of SARS-CoV-2 were detected in Wuhan, China, and by early 2020 the first cases were identified in the United States. SARS-CoV-2 infections increased in the US causing many ...

BOSTON, March 30, 2021 /PRNewswire/ -- binx health, a population health technology company that provides convenient healthcare solutions, announced today that the US Food and Drug Administration (FDA) ...

To maintain the quality of laboratory testing, CLIA requires that laboratories performing moderate or high-complexity testing enroll in an approved proficiency testing program for independent ...

Demand for COVID-19 tests, including over-the-counter at-home tests, has soared with the surge of the Omicron variant of the COVID-19 virus. However, health care providers, employers, and individuals ...

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers In all, 142 (95%) of 150 questionnaires were completed by 38 ...

“We have been working with Todos Medical for several months and believe they’ve put together the most comprehensive set of testing solutions that our organization needs to effectively execute our ...

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that it has received CLIA Licensure from the State of California that permits ...